Financhill
Back

Intellia Therapeutics, Inc. Vs. Perspective Therapeutics, Inc. Industry Stock Comparison

Sell
20

NTLA
Intellia Therapeutics, Inc.

Last Price:
$9.14
Seasonality Move:
-4.79%
Buy
56

CATX
Perspective Therapeutics, Inc.

Last Price:
$2.7300
Seasonality Move:
28.22%
Sell
20
Intellia Therapeutics, Inc. (NTLA) is a Sell

Is Intellia Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Intellia Therapeutics, Inc. [NTLA] share price is $9.44. The Score for NTLA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
56
Perspective Therapeutics, Inc. (CATX) is a Buy

Is Perspective Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Perspective Therapeutics, Inc. [CATX] share price is $2.8800. The Score for CATX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • CATX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NTLA Stock Price Chart

What is Intellia Therapeutics, Inc.'s stock price today?

  • The Intellia Therapeutics, Inc. share price today is $9.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics, Inc.'s stock price today?

  • The Perspective Therapeutics, Inc. share price today is $2.8800
    The current trend is moderately bullish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 45.9 Sell
Chaikin Money Flow: 673124 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.51 - 9.53) Buy
Bollinger Bands (100): (7.96 - 18.9) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 59.5 Buy
Chaikin Money Flow: 578231 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.1984 - 2.7184) Buy
Bollinger Bands (100): (2.4092 - 3.8092) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.27 Buy
20-day SMA: 9.2 Buy
50-day SMA: 12.11 Sell
200-day SMA: 11.33 Sell
8-day EMA: 9.36 Buy
20-day EMA: 9.47 Sell
50-day EMA: 11.13 Sell
200-day EMA: 12.74 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.74 Buy
20-day SMA: 2.53 Buy
50-day SMA: 2.64 Buy
200-day SMA: 3.01 Sell
8-day EMA: 2.75 Buy
20-day EMA: 2.61 Buy
50-day EMA: 2.7 Buy
200-day EMA: 3.58 Sell

Intellia Therapeutics, Inc. Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.38 per share.

Perspective Therapeutics, Inc. Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.45 per share, and a decrease next year of $0.14 per share.

Intellia Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):